CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Oxford Gene Technology has entered into a deal with Baylor Miraca Genetics Laboratories, licensing the use of OGT’s proprietary single nucleotide polymorphism array probe technology. This novel technology overcomes the limitations of restriction enzyme-based SNP probe approaches previously employed at BMGL for loss of heterozygosity detection, allowing accurate array-based analysis of low-input DNA samples.
Oxford Gene Technology, +44 (0) 1865 856826